Magdalena Marciniak, Ph.D.
Prepare for Meeting →Advisor
i&i BioCheck size: €150K for company creation and roughly €500K-€2M for initial venture investments, as published by i&i Bio.
Investment Thesis
Magdalena Marciniak, Ph.D. is listed in a Advisor capacity at i&i Bio. The firm does not publish a person-specific investment mandate for this role; the firm's strategy is included only as shared organizational context.
What Excites Them
Validated science, protectable intellectual property, credible translational plans and founders who can move discoveries toward clinical or commercial milestones.
What They Pass On
No formal pass list is public. Projects without strong scientific validation, life-science relevance or a feasible development path appear less aligned.
How to Pitch
This is not presented as a direct investor role. Use i&i Bio's official fundraising channel and address an investment-team member; the firm's published pitch context is: Present the science, validation, IP, development and regulatory path, team, milestone budget and why i&i Bio's regional network matters.
Notable Writing
No writing has been linked yet. Kit can search for posts, interviews, and fund essays worth reading before outreach.
Podcast Appearances
No podcast appearances are linked yet. Ask Kit to check for interviews that reveal how this investor thinks.
Key Quotes
Quote coverage is incomplete. Kit can look for direct comments on markets, founders, and investment criteria.
Background
Magdalena Marciniak, Ph.D. is a current Advisor at i&i Bio. i&i Bio says she has more than ten years across healthcare, biotechnology and consumer goods, specializing in commercialization and strategic partnerships.